• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本人硫嘌呤甲基转移酶(TPMT)基因的等位基因频率。

Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.

作者信息

Kumagai K, Hiyama K, Ishioka S, Sato H, Yamanishi Y, McLeod H L, Konishi F, Maeda H, Yamakido M

机构信息

Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

出版信息

Pharmacogenetics. 2001 Apr;11(3):275-8. doi: 10.1097/00008571-200104000-00012.

DOI:10.1097/00008571-200104000-00012
PMID:11337944
Abstract

Polymorphisms at three loci in the thiopurine methyltransferase (TPMT) gene are known to be responsible for azathioprine and 6-mercaptopurine (6MP) toxicity. Among them, only TPMT*3C variant allele with A719G mutation was found in 15/522 (2.9%; 17/1044 alleles; 1.6%) Japanese individuals including two homozygotes. The allele frequency was different from that in Caucasians, and investigation of TPMT polymorphisms with consideration of ethnic differences before administration of azathioprine or 6MP may provide clinically useful information.

摘要

已知硫嘌呤甲基转移酶(TPMT)基因三个位点的多态性与硫唑嘌呤和6-巯基嘌呤(6MP)的毒性有关。其中,在522名日本个体中有15名(2.9%;1044个等位基因中有17个,占1.6%)检测到带有A719G突变的TPMT*3C变异等位基因,其中包括两名纯合子。该等位基因频率与白种人不同,在使用硫唑嘌呤或6MP之前考虑种族差异对TPMT多态性进行研究可能会提供临床有用信息。

相似文献

1
Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.日本人硫嘌呤甲基转移酶(TPMT)基因的等位基因频率。
Pharmacogenetics. 2001 Apr;11(3):275-8. doi: 10.1097/00008571-200104000-00012.
2
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.白种人和亚洲人群中硫嘌呤甲基转移酶等位基因的频率及分布。
Pharmacogenetics. 1999 Feb;9(1):37-42. doi: 10.1097/00008571-199902000-00006.
3
Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population.日本人群中硫嘌呤甲基转移酶多态性的遗传分析。
Mutat Res. 2000 Mar 14;448(1):91-5. doi: 10.1016/s0027-5107(00)00004-x.
4
Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations.东南亚人群中硫嘌呤S-甲基转移酶等位基因的分子分析。
Pharmacogenetics. 2002 Apr;12(3):191-5. doi: 10.1097/00008571-200204000-00003.
5
The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.伊朗南部人群中巯嘌呤 S-甲基转移酶等位基因的频率和分布。
Mol Biol Rep. 2012 Apr;39(4):4581-7. doi: 10.1007/s11033-011-1248-6. Epub 2011 Sep 22.
6
Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的硫嘌呤甲基转移酶基因多态性
Digestion. 2009;79(1):58-63. doi: 10.1159/000205268. Epub 2009 Feb 28.
7
Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.
Pharmacogenetics. 1999 Dec;9(6):773-6. doi: 10.1097/00008571-199912000-00012.
8
Thiopurine methyltransferase polymorphisms in a Brazilian population.巴西人群中的硫嘌呤甲基转移酶多态性
Pharmacogenomics J. 2003;3(3):178-82. doi: 10.1038/sj.tpj.6500175.
9
[Mutant thiopurine S-methyltransferase alleles among Jing Chinese in Guangxi province].[广西京族人群中的硫嘌呤甲基转移酶突变等位基因]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Aug;20(4):303-6.
10
Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.
Clin Pharmacol Ther. 1997 Jul;62(1):60-73. doi: 10.1016/S0009-9236(97)90152-1.

引用本文的文献

1
[Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].[TPMT和NUDT15基因多态性对成人急性淋巴细胞白血病6-巯基嘌呤治疗耐受性的影响]
Zhonghua Xue Ye Xue Za Zhi. 2021 Nov 14;42(11):911-916. doi: 10.3760/cma.j.issn.0253-2727.2021.11.005.
2
Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study.1419例中国患者代谢酶基因多态性与硫唑嘌呤诱导的骨髓抑制之间的关联:一项回顾性研究
Front Pharmacol. 2021 May 18;12:672769. doi: 10.3389/fphar.2021.672769. eCollection 2021.
3
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.
亚太肝脏研究协会临床实践指南:自身免疫性肝炎患者的诊断与管理
Hepatol Int. 2021 Apr;15(2):223-257. doi: 10.1007/s12072-021-10170-1. Epub 2021 May 4.
4
Thiopurine-induced Myelosuppression with Severe Sepsis in a Patient with Crohn's Disease: A Case Report.硫唑嘌呤诱发克罗恩病患者骨髓抑制并伴严重脓毒症:一例报告
Indian J Crit Care Med. 2021 Feb;25(2):228-230. doi: 10.5005/jp-journals-10071-23738.
5
The Association Between Azathioprine Genetic Polymorphisms, Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases.埃及自身免疫性疾病患者中硫唑嘌呤基因多态性、临床疗效及药物不良反应之间的关联
Pharmgenomics Pers Med. 2021 Feb 2;14:179-187. doi: 10.2147/PGPM.S285033. eCollection 2021.
6
Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.风湿病学家的精准医学:硫唑嘌呤药物基因组学的经验教训。
Clin Rheumatol. 2021 Jan;40(1):65-73. doi: 10.1007/s10067-020-05258-2. Epub 2020 Jul 2.
7
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease.炎症性肠病患者的NUDT15基因变异与硫嘌呤诱导的白细胞减少症
Intest Res. 2020 Jul;18(3):275-281. doi: 10.5217/ir.2020.00002. Epub 2020 Jun 3.
8
Association between the c.415C > T, c.52G > A, and 36_37insGGAGTC polymorphisms of and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis.[基因名称]的c.415C>T、c.52G>A和36_37insGGAGTC多态性与硫嘌呤诱导的白细胞减少、硫嘌呤不耐受及严重脱发之间的关联:一项更新的荟萃分析
Drug Des Devel Ther. 2019 Aug 5;13:2729-2744. doi: 10.2147/DDDT.S210512. eCollection 2019.
9
Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease.印度炎症性肠病患者的硫嘌呤代谢物水平与毒性
JGH Open. 2017 Sep 18;1(1):25-31. doi: 10.1002/jgh3.12004. eCollection 2017 Sep.
10
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.硫嘌呤甲基转移酶基因多态性对埃及急性淋巴细胞白血病患儿的影响。
J Genet. 2017 Dec;96(6):905-910. doi: 10.1007/s12041-017-0853-0.